ASCOT: a tale of two treatment regimens

Editorial

Claire McDougall et al. BMJ. 2005.

. 2005 Oct 15;331(7521):859-60.

doi: 10.1136/bmj.331.7521.859.

No abstract available

Comment in

ASCOT: a tale of two treatment regimens: odds are that it's hype.
Duerden MG. Duerden MG. BMJ. 2005 Oct 29;331(7523):1022-3. doi: 10.1136/bmj.331.7523.1022-b. BMJ. 2005. PMID: 16254307 Free PMC article. No abstract available.
ASCOT: a tale of two treatment regimens: is ASCOT-BPLA being hyped-up?
Burrill PD. Burrill PD. BMJ. 2005 Oct 29;331(7523):1022. doi: 10.1136/bmj.331.7523.1022-a. BMJ. 2005. PMID: 16254308 Free PMC article. No abstract available.
ASCOT: a tale of two treatment regimens: don't lose your head over ASCOT.
Phizackerley DG. Phizackerley DG. BMJ. 2005 Oct 29;331(7523):1022. doi: 10.1136/bmj.331.7523.1022. BMJ. 2005. PMID: 16254309 Free PMC article. No abstract available.
ASCOT: a tale of two treatment regimens: is ASCOT all it's cracked up to be?
Cave JA. Cave JA. BMJ. 2005 Oct 29;331(7523):1023. doi: 10.1136/bmj.331.7523.1023. BMJ. 2005. PMID: 16254312 Free PMC article. No abstract available.

Angiotensin receptor blockers and risk of myocardial infarction: systematic review.
McDonald MA, Simpson SH, Ezekowitz JA, Gyenes G, Tsuyuki RT. McDonald MA, et al. BMJ. 2005 Oct 15;331(7521):873. doi: 10.1136/bmj.38595.518542.3A. Epub 2005 Sep 23. BMJ. 2005. PMID: 16183653 Free PMC article.